Matches in Wikidata for { <http://www.wikidata.org/entity/Q91209495> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q91209495 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91209495 description "scientific article published on 22 October 2019" @default.
- Q91209495 description "wetenschappelijk artikel" @default.
- Q91209495 description "наукова стаття, опублікована 22 жовтня 2019" @default.
- Q91209495 name "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 name "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 type Item @default.
- Q91209495 label "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 label "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 prefLabel "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 prefLabel "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 P1433 Q91209495-DC15BFFB-F939-4B49-BCCF-17C027D6253C @default.
- Q91209495 P1476 Q91209495-05F6E77A-FD48-4BD8-897E-C8B376AE42E1 @default.
- Q91209495 P2093 Q91209495-32745F30-C637-48D7-8F2F-C8EC9D25CFF4 @default.
- Q91209495 P2093 Q91209495-AEBA7124-ACD1-49A9-82BB-87D8F60339F4 @default.
- Q91209495 P2860 Q91209495-64688282-5FF5-4608-8128-C9D5FD14F006 @default.
- Q91209495 P304 Q91209495-7F5207C9-CAF8-4AE2-BCA9-0E56753FEC5E @default.
- Q91209495 P31 Q91209495-D989C4F7-3300-4195-A30F-FF52926B52C8 @default.
- Q91209495 P356 Q91209495-D7719EC1-57AF-4A12-A830-3FDA7F003AC3 @default.
- Q91209495 P478 Q91209495-70C5A6BC-4A26-4347-AE6A-43877975E1E1 @default.
- Q91209495 P50 Q91209495-AC43A8EE-9FDD-4218-9B67-7489CF1F4EBE @default.
- Q91209495 P50 Q91209495-DE1CC87B-130C-45FD-8876-3103B3AC129A @default.
- Q91209495 P577 Q91209495-51360480-D57C-4546-A6B8-121A8695BD10 @default.
- Q91209495 P698 Q91209495-436746EF-A488-4132-BAEF-7BDD9FD235FA @default.
- Q91209495 P356 J.NUCMEDBIO.2019.10.001 @default.
- Q91209495 P698 31706737 @default.
- Q91209495 P1433 Q7067979 @default.
- Q91209495 P1476 "Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR" @default.
- Q91209495 P2093 "Humphrey Fonge" @default.
- Q91209495 P2093 "Karen Lam" @default.
- Q91209495 P2860 Q28365506 @default.
- Q91209495 P304 "37-44" @default.
- Q91209495 P31 Q13442814 @default.
- Q91209495 P356 "10.1016/J.NUCMEDBIO.2019.10.001" @default.
- Q91209495 P478 "80-81" @default.
- Q91209495 P50 Q107786917 @default.
- Q91209495 P50 Q89349001 @default.
- Q91209495 P577 "2019-10-22T00:00:00Z" @default.
- Q91209495 P698 "31706737" @default.